Clinical Trial Update: Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults [Phase 1]

View source ↗

Summary

A Phase 1 study by Sanaria Inc. to optimize controlled human malaria infection using Plasmodium falciparum sporozoites in non-immune adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Challenge (P. falciparum sporozoites)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria | Phase 1 | Status: COMPLETED